Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on ...

Ipsen’s Kayfanda (odevixibat) has been approved by the European Commission (EC) under exceptional circumstances to treat ...

Johnson & Johnson (J&J) and Legend Biotech have shared positive long-term results for their BCMA-directed T-cell ...

More and more health data is being collected in the real-world about how that medicine works in a wider population than that ...

Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people ...

Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission ...

Effective brand strategies are like a well-made jigsaw but they can end up looking nothing like the picture that was agreed ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

One of the candidates included in the deal has already shown promise in a phase 1a advanced breast cancer study ...

Many initiatives have tried to address this partnership challenge: the Healthcare Communications Association’s (HCA) own ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu ...

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, ...